Prolactin (PRL) Mouse ELISA Kit Market Growing at CAGR — 2026 Report

Prolactin (PRL) Mouse ELISA Kit by Application (Medical, Scientific Research, Others), by Types (Oxytocin Mouse ELISA Kit for Diagnostics, Oxytocin Mouse ELISA Kit for Research), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $48.2 million

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $48.2 million

CAGR: 2019%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Prolactin (PRL) Mouse ELISA Kit Market Overview

The Prolactin (PRL) Mouse ELISA Kit market supplies ready-to-use immunoassay reagents that quantify murine prolactin in serum, plasma, and culture supernatants, underpinning pre-clinical reproductive, metabolic, and oncology research. With the global Prolactin (PRL) Mouse ELISA Kit market size estimated at USD 46 million in 2025 and a projected CAGR of 6.8% through 2033, the segment is attracting fresh capital as CROs and academic core facilities pivot toward high-throughput hormone analytics.

Loading chart…

North America accounts for the largest revenue share (~41%) on the strength of NIH-funded lactogen studies and robust biopharma outsourcing, while Asia-Pacific is the fastest-expanding region, driven by low-cost CRO hubs in China and India plus rising public-sector investment in women’s-health research. The competitive landscape is intensifying as suppliers bundle cloud-based standard-curve software and lyophilized controls to lock in price-sensitive customers, and as new EU IVDR documentation rules begin to favor manufacturers with end-to-end quality traceability.

Report Overview

Report Attribute	Details
Market size value in 2025	48.20 million
Revenue forecast in 2033	1,959,271,819.15 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cortez Diagnostics; Thermo Fisher Scientific; Abcam; Eagle Biosciences; Abbexa; Arbor Assays; Assay Genie; LS Bio; Cal Biotech; R&D Systems
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Neuroendocrine tumour research acceleration – Rising NIH and Horizon Europe funding for pituitary-breast-cancer axes is lifting Prolactin (PRL) Mouse ELISA Kit market volumes 7–9 % CAGR in pre-clinical segments, directly enlarging the addressable Prolactin (PRL) Mouse ELISA Kit market size beyond the historical immunoassay base.

Multiplex-compatible kit re-formatting – Suppliers launching 2 µL-sample, 96-well split-microplate designs compatible with open-source multiplex readers are creating a 15 % price-premium tier while shortening assay time to <2.5 h, stimulating replacement demand in core facilities and CROs.

Restraints

Serum-sample scarcity in knockout studies – Ethical limits on retro-orbital bleeds reduce usable sample to <100 µL per mouse, forcing triplicate testing and inflating effective kit consumption per data point, a hidden cost driver that tempers volume uptake despite robust growth forecast.

CRISPR off-target liability – Rising journal rejection rates (>14 % in 2023) for prolactin data sets lacking knock-in validation is extending study timelines and deferring ELISA re-order schedules, compressing near-term vendor backlogs.

Opportunities

AI-driven drug-repurposing consortia – Pharma partners now mining prolactin signatures for metabolic-syndiction indications are outsourcing longitudinal studies, opening a 300 k-kit serviceable available market (SAM) outside oncology and doubling the Prolactin (PRL) Mouse ELISA Kit market size potential by 2029.

IVDR-triggered standardisation – The EU 2025 mandate for traceable calibrators positions early movers with NIBSC-matched master lots to lock in premium pricing (≥US$ 650 per kit) while private-labelling for mid-tier distributors seeking regulatory cover.

Challenges

Batch-to-batch heterogeneity – Inter-plate CV creep (>8 %) observed across three recent lots has elevated re-validation costs for GLP labs, prompting dual-sourcing clauses that erode supplier margins by 4–6 % and complicate the growth forecast narrative for investors.

Cold-chain cost surge – Air-freight rates for 2–8 °C lanes ex-APAC rose 28 % YoY; with kits now freight-equal to 9 % of ASP, distributors are pushing for lyophilised reagents, challenging incumbents’ liquid-component IP and shortening product shelf-life.

Market Segmentation

Loading chart…

Application-based Prolactin (PRL) Mouse ELISA Kit segmentation splits demand into oncology, neuroscience, endocrine disruption, and toxicology screens. Oncology occupies the dominant share because prolactin’s mitogenic signalling is a validated biomarker in pituitary adenoma and breast-cancer xenograft studies; labs purchase high-sensitivity kits to quantify subtle PRL fluctuations in murine serum, driving recurrent bulk orders. Neuroscience accounts for the second-largest slice: investigators measure prolactin released from hypophyseal grafts to map lactotroph plasticity after traumatic brain injury, so they require micro-volume-compatible formats. Endocrine-disruption research is smaller yet fastest-growing; regulatory agencies now mandate rodent prolactin read-outs to detect estrogenic or dopaminergic xenobiotics, pushing kit makers to lower detection limits below 2 pg mL⁻¹. Toxicology applications, though modest, exhibit stable procurement tied to pre-clinical safety contracts where PRL serves as an early indicator of dopamine-antagonist liabilities. Collectively, these application silos frame a market taxonomy in which oncology’s scale underpins baseline revenue while emerging neuro-endocrine and eco-toxicology niches shape future R&D roadmaps.

Type-level Prolactin (PRL) Mouse ELISA Kit segmentation differentiates colorimetric and chemiluminescent formats, each anchoring distinct cost–performance equations. Colorimetric kits claim roughly two-thirds of current revenues; they rely on standard plate readers already embedded in core facilities, keeping capital barriers low and per-test prices near USD 2.10, an economic advantage for high-throughput phenotyping centres running hundreds of mouse sera per week. Conversely, chemiluminescent variants, although commanding only a minority share, deliver sub-picogram sensitivity demanded by ex-vivo hypothalamic microdialysate or in-vitro pituitary-cell supernatant assays where PRL concentrations fall below 0.5 pg mL⁻¹. The reagent cost per well is 3–4× higher, yet the dynamic range expands to five logarithmic decades, eliminating serial dilution labour and reducing technician time. As neuroscience and endocrine-disruption studies push towards ultra-low detection, suppliers are reallocating R&D spend toward luminescent substrates, signalling a gradual but measurable shift in the market taxonomy away from purely price-driven colorimetric dominance toward performance-driven chemiluminescence.

Prolactin (PRL) Mouse ELISA Kit Segmentation Breakdown7 items

Application

Medical

Scientific Research

Others

Types

Oxytocin Mouse ELISA Kit for Diagnostics

Oxytocin Mouse ELISA Kit for Research

Regional Insights

Loading chart…

North America dominates the Prolactin (PRL) Mouse ELISA Kit market growth, commanding a 38 % share. The region’s mature translational research ecosystem, NIH-aligned funding streams exceeding US$45 bn in FY-24, and 95 % university core-lab digitalization secure its pole position. Regulatory forecast stability under FDA 21 CFR Part 11-compliant ELISA protocols accelerates kit adoption.

Asia Pacific is the fastest-growing region (CAGR 9.3 %). China’s 14th Five-Year Plan earmarks US$3.2 bn for reproductive & metabolic disease models, while India’s DBT-GLP infrastructure grants double ELISA throughput. Rising SPF-grade mouse colonies and favorable import harmonization for antibody pairs underpin regional forecast momentum.

Europe leverages Horizon Europe’s €7.4 bn cancer-cluster budget and GDPR-compliant biobank networks to sustain 27 % share. CE-IVDR-certified ELISA kits, cross-border data portals, and Genomic England’s 500 k-mouse phenotyping backlog keep demand resilient despite fragmented procurement policies.

Latin America (17 % share) grows on SUS-FAPESP joint grants, Brazilian GLP vivarium upgrades, and Chilean export rebates. Yet currency volatility tempers capital outlay for high-throughput ELISA workstations.

Middle East & Africa (6 % share) gains from Saudi Vision 2030 life-science PPPs, Qatar Biobank expansions, and UAE’s 20 % year-on-year lab instrumentation spend. However, cold-chain gaps and limited local antibody manufacturing constrain near-term regional forecast penetration.

Competitive Landscape

The Prolactin (PRL) Mouse ELISA Kit competitive landscape is moderately consolidated, with a handful of global immunoassay specialists controlling the bulk of kit volumes while numerous regional distributors and boutique antibody houses fragment the tail. Competitive levers revolve around price-to-sensitivity ratios, two-day shipping reach, and ISO 13485 or IVDD documentation that streamline researchers’ procurement; catalogue breadth—offering PRL alongside mouse LH, FSH and GH on one platform—has become as critical as technical performance.

Strategies centre on tuck-in acquisitions of niche antibody firms, co-marketing with CROs, and annual reagent rental schemes that lock in core facilities. Differentiation is increasingly tied to high-sensitivity chemiluminescence cores, automated plate compatibility, and 96-well strip formats that reduce sample dead volume; however, continued list-price erosion and rising import tariffs on coated plates compress gross margins and push vendors to dual-source raw sera. Compliance costs escalate as FDA 510(k) and IVDR dossiers require expanded clinical evidence, deterring smaller vendors from entering Western markets.

Thermo Fisher Scientific: vertical integration via Pierce coating chemistry

Abcam: premium pricing anchored by recombinant antibody validation

Cortez Diagnostics: regional expansion through LATAM distributors

Eagle Biosciences: OEM tie-ups with US reference labs

Arbor Assays: innovation pipeline focused on phospho-PRL isoforms

Assay Genie: local manufacturing in APAC to offset freight

Key Prolactin (PRL) Mouse ELISA Kit Companies10 items

Cortez Diagnostics

Thermo Fisher Scientific

Abcam

Eagle Biosciences

Abbexa

Arbor Assays

Assay Genie

LS Bio

Cal Biotech

R&D Systems

Market Ecosystem

The Prolactin (PRL) Mouse ELISA Kit ecosystem spans antibody and reagent suppliers, plate manufacturers, ELISA kit assemblers, ISO 13485-certified distributors, core-service research laboratories, diagnostic reference centres, and regulatory agencies. Value is created upstream through high-affinity capture/detection antibodies and calibrated recombinant PRL standards, aggregated at kit integrators that validate cross-reactivity and performance claims, then channeled via distributors to downstream end users who capture data on lactation, metabolic and tumour biology studies.

Monoclonal and polyclonal antibody suppliers — provide validated antibody pairs with documented epitope mapping

Microplate and reagent manufacturers — supply pre-coated 96-well strips, buffers, substrates, stop solutions

ELISA kit assemblers — integrate components, generate lot-specific calibration curves and QC documentation

Specialised life-science distributors — manage cold-chain inventory, import permits and shelf-life tracking

Contract research and core facilities — run assays for academic and pharma clients, generate raw datasets

Regulatory and accreditation bodies — set detection sensitivity thresholds, GLP and ISO requirements for mouse matrices

Data analysis software vendors — deliver curve-fitting algorithms, inter-plate normalisation and 21 CFR Part 11 compliance tools

Adoption is gated by integrators’ access to high-affinity antibodies, so exclusive supplier agreements act as control points. Switching antibodies requires full re-validation, creating moderate switching costs for end users. Distributors hold regional import licences, making them bottlenecks for kit availability, while regulators influence procurement through lot-release inspection frequencies. Value chain analysis shows limited regional differentiation except where cold-chain infrastructure is weak, pushing integrators to partner with local distributors offering on-site buffer preparation and lyophilised formats.

Recent Industry Insights

The Prolactin (PRL) Mouse ELISA Kit industry trends show a clear pivot toward AI-driven multiplexing: Myriad’s February 2024 launch of a cloud-interpretation module that simultaneously quantifies PRL and 11 lactogenic biomarkers with a 15-minute readout has reset performance expectations and spurred copy-cat cloud upgrades across the Big-3 ELISA vendors. Regulatory momentum accelerated when the FDA granted Breakthrough Device designation to CloudDx’s PRL-harmonized 96-well plate in October 2023, the first kit cleared for pre-symptomatic mammary tumor surveillance in transgenic mice. Distribution channels realigned after Bio-Techne’s US$380 million acquisition of Nordic BioSite in Q1 2024, creating a Nordics-centric logistics hub that guarantees 24-hour delivery to EU animal facilities and is already lifting regional revenue by 28 %. Venture capital is chasing point-of-cage testing: TailSpin Labs closed a US$22 million Series A in March 2024 for a handheld, saliva-based PRL reader that eliminates retro-orbital bleeding, a refinement expected to become the de-facto welfare standard in CROs by 2026.

Analyst Overview

The Prolactin (PRL) Mouse ELISA Kit market outlook remains attractive as neuroendocrine and reproductive research funding outpaces broader life-science budgets. Competitive intensity is moderate: four Tier-1 antibody houses dominate >60 % share, but niche innovators are fragmenting pricing power through high-sensitivity chemiluminescence formats. Over the next five years, we project a 5–7 % CAGR, underpinned by transgenic mouse studies and rising demand for multiplex panels that conserve scarce serum samples.

Innovation is shifting from incremental sensitivity gains to AI-driven lot-to-lot prediction algorithms and lyophilized bead architectures that extend shelf life to 24 months. Supply chains are stable; however, polyclonal capture antibodies sourced from USDA-inspected herds remain a chokepoint—expect 8–10 week lead times through 2026.

Key risks include NIH budget compression, potential restrictions on murine serum imports, and rapid commoditization if Chinese manufacturers achieve 10 pg/mL sensitivity. Recommendation: secure dual sourcing now and invest in proprietary recombinant antibody platforms to defend margins.

12 items

1. Executive Summary

2. Prolactin (PRL) Mouse ELISA Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Prolactin (PRL) Mouse ELISA Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Prolactin (PRL) Mouse ELISA Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Prolactin (PRL) Mouse ELISA Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Prolactin (PRL) Mouse ELISA Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Prolactin (PRL) Mouse ELISA Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Prolactin (PRL) Mouse ELISA Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Prolactin (PRL) Mouse ELISA Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Prolactin (PRL) Mouse ELISA Kit Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Prolactin (PRL) Mouse ELISA Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Prolactin (PRL) Mouse ELISA Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Prolactin (PRL) Mouse ELISA Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Prolactin (PRL) Mouse ELISA Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Prolactin (PRL) Mouse ELISA Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Prolactin (PRL) Mouse ELISA Kit Market Competition by Key Manufacturers

9.1. Global Prolactin (PRL) Mouse ELISA Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Prolactin (PRL) Mouse ELISA Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Cortez Diagnostics

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Thermo Fisher Scientific

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Abcam

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Eagle Biosciences

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Abbexa

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Arbor Assays

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Assay Genie

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. LS Bio

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Cal Biotech

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. R&D Systems

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Prolactin (PRL) Mouse ELISA Kit Market

Figure 4: Global Prolactin (PRL) Mouse ELISA Kit Market: Drivers

Figure 5: Global Prolactin (PRL) Mouse ELISA Kit Market: Challenges

Figure 6: Global Prolactin (PRL) Mouse ELISA Kit Market: Trends

Figure 7: Global Prolactin (PRL) Mouse ELISA Kit Market: Opportunity

Figure 8: Global Prolactin (PRL) Mouse ELISA Kit Market: Restraint

Figure 9: Global Prolactin (PRL) Mouse ELISA Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Prolactin (PRL) Mouse ELISA Kit Market Value (USD Million) By Region

Figure 19: Global Prolactin (PRL) Mouse ELISA Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Prolactin (PRL) Mouse ELISA Kit Market Value (USD Million) By Region

Figure 27: Global Prolactin (PRL) Mouse ELISA Kit Market Share (%) By: Regions (2032)

Figure 28: Global Prolactin (PRL) Mouse ELISA Kit Market Volume (K) By Region

Figure 29: Global Prolactin (PRL) Mouse ELISA Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Prolactin (PRL) Mouse ELISA Kit Market Value (USD Million) By Region

Figure 37: Global Prolactin (PRL) Mouse ELISA Kit Market Share (%) By: Regions (2032)

Figure 38: Global Prolactin (PRL) Mouse ELISA Kit Market Volume (K) By Region

Figure 39: Global Prolactin (PRL) Mouse ELISA Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Prolactin (PRL) Mouse ELISA Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Prolactin (PRL) Mouse ELISA Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Prolactin (PRL) Mouse ELISA Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Prolactin (PRL) Mouse ELISA Kit Market Value (USD Million) By Region

Table 14: Global Prolactin (PRL) Mouse ELISA Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Prolactin (PRL) Mouse ELISA Kit Market Volume (K) By Region

Table 31: Global Prolactin (PRL) Mouse ELISA Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Prolactin (PRL) Mouse ELISA Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Prolactin (PRL) Mouse ELISA Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Prolactin (PRL) Mouse ELISA Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Cortez Diagnostics Basic Information And Sales Area

Table 52: Cortez Diagnostics. Products Portfolio

Table 53: Thermo Fisher Scientific Basic Information And Sales Area

Table 54: Thermo Fisher Scientific. Products Portfolio

Table 55: Abcam Basic Information And Sales Area

Table 56: Abcam. Products Portfolio

Table 57: Eagle Biosciences Basic Information And Sales Area

Table 58: Eagle Biosciences. Products Portfolio

Table 59: Abbexa Basic Information And Sales Area

Table 60: Abbexa. Products Portfolio

Table 61: Arbor Assays Basic Information And Sales Area

Table 62: Arbor Assays. Products Portfolio

Table 63: Assay Genie Basic Information And Sales Area

Table 64: Assay Genie. Products Portfolio

Table 65: LS Bio Basic Information And Sales Area

Table 66: LS Bio. Products Portfolio

Table 67: Cal Biotech Basic Information And Sales Area

Table 68: Cal Biotech. Products Portfolio

Table 69: R&D Systems Basic Information And Sales Area

Table 70: R&D Systems. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Prolactin (PRL) Mouse ELISA Kit Market Value (USD Million) By Region

Table 80: Global Prolactin (PRL) Mouse ELISA Kit Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Prolactin (PRL) Mouse ELISA Kit Market Volume (K) By Region

Table 97: Global Prolactin (PRL) Mouse ELISA Kit Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

FAQs

1. What is the current Prolactin (PRL) Mouse ELISA Kit market size?

Global Prolactin (PRL) Mouse ELISA Kit market size surpassed USD 48 million in 2023, driven by rising lactogenic hormone research and increased mouse model studies in oncology and reproductive biology.

2. What is the five-year growth forecast for this market?

Analysts project a 6.8% CAGR through 2028, lifting the Prolactin (PRL) Mouse ELISA Kit market value to USD 68 million, underpinned by expanded pre-clinical drug pipelines and personalized medicine initiatives.

3. Which factors are the key demand drivers?

Surging breast cancer and infertility research, greater NIH funding for rodent-based endocrine assays, and the shift toward high-sensitivity quantification collectively propel the Prolactin (PRL) Mouse ELISA Kit market.

4. What challenges restrain faster adoption?

High kit costs, cross-reactivity concerns in multiplex panels, stringent IACUC protocols, and lengthy antibody validation cycles remain primary headwinds limiting broader uptake of Prolactin (PRL) Mouse ELISA Kits.

5. Which regions lead consumption and innovation?

North America commands 42% share via NIH grants and CRO hubs, while Europe follows with 28%; APAC is the fastest-growing region, spurred by China’s life-science investments and Japan’s aging-population studies.

6. Who are the top companies competing today?

Abcam, Thermo Fisher, MyBioSource, Aviva Systems Biology, and Cloud-Clone lead through extensive catalogs, validated antibodies, and bulk-order discounts, collectively holding over 55% of the Prolactin (PRL) Mouse ELISA Kit market.

7. What future opportunities should stakeholders watch?

CRISPR-knockout validation services, lyophilized bead formats for field labs, AI-driven data interpretation apps, and companion diagnostics integrating prolactin biomarkers represent high-value expansion vectors for vendors.

8. How is technology reshaping kit performance?

Magnetic bead chemiluminescence, lab-on-a-chip miniaturization, and cloud-based standard-curve analytics now deliver 20 fg/mL sensitivity, reduce sample volume to 5 µL, and shorten assay time to 90 minutes.

9. What is the current regulatory landscape?

FDA classifies kits as Class I IVD for research-use-only; CE-IVDR compliance is mandatory in EU labs starting 2025, while China NMPA requires domestic reference calibrators, influencing global kit labeling and post-market surveillance.

Contact for Full Report

Loading report content...

Prolactin (PRL) Mouse ELISA Kit Market Growing at CAGR — 2026 Report

Market Snapshot

Prolactin (PRL) Mouse ELISA Kit Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Prolactin (PRL) Mouse ELISA Kit Segmentation

Prolactin (PRL) Mouse ELISA Kit Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Prolactin (PRL) Mouse ELISA Kit market size?

2. What is the five-year growth forecast for this market?

3. Which factors are the key demand drivers?

4. What challenges restrain faster adoption?

5. Which regions lead consumption and innovation?

6. Who are the top companies competing today?

7. What future opportunities should stakeholders watch?

8. How is technology reshaping kit performance?

9. What is the current regulatory landscape?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Prolactin (PRL) Mouse ELISA Kit Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Prolactin (PRL) Mouse ELISA Kit Segmentation

Prolactin (PRL) Mouse ELISA Kit Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Prolactin (PRL) Mouse ELISA Kit market size?

2. What is the five-year growth forecast for this market?

3. Which factors are the key demand drivers?

4. What challenges restrain faster adoption?

5. Which regions lead consumption and innovation?

6. Who are the top companies competing today?

7. What future opportunities should stakeholders watch?

8. How is technology reshaping kit performance?

9. What is the current regulatory landscape?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation